First Atom Therapeutics

First Atom Therapeutics is a pre-clinical stage biotechnology company leveraging a proprietary physics-driven platform to discover and develop novel small molecule therapeutics. By integrating high-fidelity molecular dynamics simulations with machine learning, the company aims to unlock previously 'undruggable' targets with high precision. Headquartered in Waltham, Massachusetts, First Atom is currently advancing an internal pipeline focused on high-impact indications in oncology and immunology. The company's approach is designed to significantly accelerate the hit-to-lead process and optimize drug-like properties early in development. First Atom is backed by prominent venture capital firms and led by a team with deep expertise in computational chemistry and drug discovery.